ArticleBMC microbiology2025
Novilysobacter viscosus sp. Nov. and Novilysobacter longmucuonensis sp. Nov., two Nov.l species capable of producing proteases and RiPPs.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
As prolific producers of extracellular lytic enzymes and antimicrobial natural products, Lysobacter strains have garnered great interest over the past decade. Three gram-stain-negative, aerobic, short rod bacterial strains with flagella, designated A3-1-A15T, D1-1-M9T and D1-1-M8, were isolated from the shore soil of Longmucuo Lake in the Xizang Autonomous Region, China. Comparisons of the 16 S rRNA gene sequences confirmed their affiliation with the genus Novilysobacter. Strain A3-1-A15T presented the highest similarity of the 16 S rRNA gene sequence to Novilysobacter selenitireducen 13AT (97.75%), whereas strains D1-1-M9T and D1-1-M8 were most closely related to Novilysobacter erysipheiresistens RS-LYSO-3T, showing 97.80% similarity. The genomic DNA G + C contents of strains A3-1-A15T, D1-1-M9T and D1-1-M8 were 67.46%, 68.79% and 67.85%, respectively, based on the genome sequence data. The ANI values of strains A3-1-A15T and D1-1-M9T with N. selenitireducens A13T and N. erysipheiresistens CICC 23,922T were 84.45%/78.03% and 79.41%/79.81%, respectively. Corresponding dDDH values were 49.7%/23.2% and 24.7%/25.4%, all below the species thresholds, confirming two novel Novilysobacter species. The main polar lipids included diphosphatidylglycerol, phosphatidylethanolamine and phosphatidylglycerol. The major cellular fatty acids were summed feature 9 (C16:0 10-methyl and/or iso-C17:1ω9c), iso-C15:0, iso-C16:0, iso-C11:0 and iso-C11:0 3-OH. Protease production was confirmed through genomic data and physiological experiments. In summary, these findings support the proposal of two novel species within the genus Novilysobacter: N. viscosus sp. nov. and N. longmucuonensis sp. nov. The type strains for N. viscosus sp. nov. and N. longmucuonensis are A3-1-A15T (= CGMCC 1.19188T = KCTC 92144T) and D1-1-M9T (= CGMCC 1.19230T = KCTC 92146T), respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.